ORTHOPEDIATRICS CORP

Orthopediatrics (KIDS) rallies 3.65% as Neo‑BONE launch, strong US contracts and disciplined valuation spark investor confidence in pediatric orthopedics.

Orthopediatrics Corp. (KIDS) rises 1.45% to $23.84, up 4.75% YTD, with a $613M market cap—an overview of its pediatric orthopedic market niche and key stock metrics.

Orthopediatrics (KIDS) jumped 6.7% to $23.50, outpacing peers, thanks to strong investor sentiment and a niche in paediatric orthopaedic devices.

Orthopediatrics (KIDS) sees only a 0.36% rise, but low volume and declining trend signal stagnant growth in the pediatric orthopedics niche.